KONINKLIJKE PHILIPS NVR- NY PHG
ASignal's systematic analysis rates PHG as Neutral.
Reflects the latest available analysis · analyzed Nov 4, 2026
The case on PHG
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Forward P/E of 15.08x suggests valuation improvement
- PEG ratio of 0.88x indicates potential undervaluation relative to growth
- Free cash flow of $1.84B supports capital return capacity
- Debt-to-equity ratio of 0.70x is within moderate range
- Dividend yield of 356.00% is exceptionally high
- RSI at 82.28 indicates overbought conditions
- Price trading above upper Bollinger Band (28.43) suggests short-term reversal risk
- Earnings growth YoY of -85.40% reflects severe profitability decline
- Operating margin of 3.76% is weak for Medical Devices sector
- ROE of 8.61% is below benchmark for healthcare peers
- Quick ratio of 0.81x raises near-term liquidity concerns
See the full verdict on PHG
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes PHG
Most investors never get a second opinion, let alone several. ASignal runs PHG past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.